Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Saturday, January 25, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG
admin
-
January 24, 2025
Latest Pharma-News
Bayer and Pula Foundation partner up to insure 10 million smallholder farmers in Sub-Saharan Africa and South Asia
admin
-
January 24, 2025
Latest Pharma-News
First participants randomized in AskBio Phase II gene therapy trial for Parkinson’s disease
admin
-
January 18, 2025
Latest Pharma-News
Johnson & Johnson initiated submission of NDA application with U.S. FDA for TAR-200 for BCG-unresponsive high-risk non-muscle-invasive bladder cancer
admin
-
January 18, 2025
Latest Pharma-News
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
admin
-
March 8, 2024
Latest Pharma-News
FDA grant Approval For Allergan’s durysta (Bimatoprost Implant) for Open-Angle Glaucoma Or Ocular Hypertension Patients
admin
-
March 6, 2020
0
Latest Pharma-News
U.S. Food and Drug Administration grants Orphan Drug Designation to TG Therapeutics for Umbralisib for the Treatment of Follicular Lymphoma
admin
-
March 6, 2020
0
Latest Pharma-News
USFDA Grants Rare Pediatric Disease Designation to Stealth BioTherapeutics for Elamipretide for the Treatment of Barth Syndrome
admin
-
March 4, 2020
0
Latest Pharma-News
FDA Informs Patients, Providers and Manufacturers About Potential Cybersecurity Vulnerabilities in the Certain Medical Devices with Bluetooth Low Energy
admin
-
March 4, 2020
0
Latest Pharma-News
KemPharm Submits KP415 NDA to USFDA for the Treatment of attention deficit hyperactivity disorder (ADHD)
admin
-
March 3, 2020
0
Latest Pharma-News
FDA grants Breakthrough Therapy Designation for Roche’s Esbriet (pirfenidone) in unclassifiable interstitial lung disease
admin
-
March 3, 2020
0
Latest Pharma-News
Coronavirus (COVID-19) Update: FDA and CDC take action to increase access to the respirators, including N95s, for the health care personnel
admin
-
March 3, 2020
0
Latest Pharma-News
FDA allows labs margin in testing for coronavirus
admin
-
March 2, 2020
0
Latest Pharma-News
USFDA Approves First Generic of Daraprim
admin
-
March 2, 2020
0
Latest Pharma-News
USFDA accepts Roche’s Biologics License Application for fixed-dose subcutaneous combination of Perjeta and Herceptin for the treatment of HER2-positive breast cancer
admin
-
February 28, 2020
0
Latest Pharma-News
Sanofi to create new industry-leading European company to provide active pharmaceutical ingredients
admin
-
February 28, 2020
0
Latest Pharma-News
AstraZeneca divests global rights to Movantik (naloxegol)
admin
-
February 27, 2020
0
1
...
126
127
128
...
145
Page 127 of 145
- Advertisment -
Most Read
Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG
January 24, 2025
Bayer and Pula Foundation partner up to insure 10 million smallholder farmers in Sub-Saharan Africa and South Asia
January 24, 2025
First participants randomized in AskBio Phase II gene therapy trial for Parkinson’s disease
January 18, 2025
Johnson & Johnson initiated submission of NDA application with U.S. FDA for TAR-200 for BCG-unresponsive high-risk non-muscle-invasive bladder cancer
January 18, 2025